Global Whole Genome Sequencing Market Size, Share, and COVID-19 Impact Analysis, By Product & Service (Instruments, Consumables, and Services), By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, and Microbial Whole Genome Sequencing), By End-use (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Whole Genome Sequencing Market Insights Forecasts to 2035

• The Global Whole Genome Sequencing Market Size Was Estimated at USD 2.05 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 22.05% from 2025 to 2035
• The Worldwide Whole Genome Sequencing Market Size is Expected to Reach USD 18.35 Billion by 2035
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Whole Genome Sequencing Market Size was worth around USD 2.05 Billion in 2024 and is Predicted to Grow to around USD 18.35 Billion by 2035 with a compound annual growth rate (CAGR) of 22.05% from 2025 to 2035. The growing prevalence of genetic disorders, increased need for oncology precision, and genomics solutions are driving the whole genome sequencing market globally.  

Market Overview

The whole genome sequencing market refers to the industry emphasizing analysis of the completed DNA sequence of an organism. Whole genome sequencing (WGS) is a comprehensive method for analyzing entire genomes. It can detect single-nucleotide variants, insertions/deletions, copy number changes, and large structural variants. Genomic information has been instrumental in identifying inherited disorders, characterizing the mutations that drive cancer progression, and tracking disease outbreaks. Further, large volumes of genetic data are processed and interpreted in genomic analysis by using AI methods such as machine learning and deep learning. Transformation of the genomics landscape, impacting the healthcare, research, and agriculture sectors, aids in promoting the whole genome sequencing market. Further, the growing demand for long-read sequencing in clinical genomics is escalating the market growth opportunities.

Report Coverage

This research report categorizes the whole genome sequencing market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the whole genome sequencing market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the whole genome sequencing market.

Driving Factors

The growing prevalence of genetic disorders is anticipated to drive the market demand for whole genome sequencing. As per the estimates of the WHO, 10 out of every 1000 people are affected by genetic diseases; that is, 70 to 80 million people worldwide are living with one of these diseases. Whole genome sequencing (WGS) provides comprehensive information on somatic point mutations, copy number alterations (CNAs), and structural variations (SVs), which are essential for precision oncology and individualized treatment plans. Technological advancements in the genomics industry, which are refining research and applications, are contributing to driving the market growth.

Restraining Factors

An increased cost of infrastructure & data management, as well as privacy concerns related to whole genome sequencing, are challenging the market. Further, the limited expertise & sequencing capabilities of small & medium-sized laboratories and a lack of sequencing professionals in developing countries are hampering the market growth. 

Market Segmentation

The whole genome sequencing market share is classified into product & service, application, and end-use.

• The consumables segment dominated the market with the largest revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product & service, the whole genome sequencing market is divided into instruments, consumables, and services. Among these, the consumables segment dominated the market with the largest revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The continuous advancement in sequencing technologies, along with an increasing emphasis on genomics research, is driving the market growth in the consumables segment.

• The human whole genome sequencing segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the whole genome sequencing market is divided into human whole genome sequencing, plant whole genome sequencing, animal whole genome sequencing, and microbial whole genome sequencing. Among these, the human whole genome sequencing segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Human whole genome sequencing is the most comprehensive application for detecting all variant types of the human genome in a single assay. It aids in the development of targeted therapies to treat diseases.

•  The academic & research institutes segment accounted for the dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end-use, the whole genome sequencing market is divided into academic & research institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others. Among these, the academic & research institutes segment accounted for the dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An increasing adoption of whole genome sequencing technologies by the academic & research institutes for drug research and genomic studies, including understanding of disease mechanisms, identifying genetic variations, and developing new therapies, is driving the market growth.

Regional Segment Analysis of the Whole Genome Sequencing Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the whole genome sequencing market over the predicted timeframe.

North America is anticipated to hold the largest share of the whole genome sequencing market over the predicted timeframe. Significant research investments by the pharmaceutical and biopharmaceutical companies, along with the region’s increased awareness about whole genome sequencing, are contributing to driving the market growth. Further, the upsurging advancements in personalized medicine, with increasing research funding, are propelling the market growth.

Asia Pacific is expected to grow at a rapid CAGR in the whole genome sequencing market during the forecast period. Genomics advancements, along with an increased prevalence of genetic disorders, are anticipated to drive the whole genome sequencing market. Further, the growing awareness about personalized medicine, government initiatives, and academic institutes' collaborations with biotech companies are significantly contributing to promoting the market.

Europe is anticipated to grow at a significant CAGR in the whole genome sequencing market during the predicted timeframe. Increasing investments in advanced sequencing technologies by the healthcare institutions, research organizations, and pharmaceutical companies are contributing to propel the market growth for whole genome sequencing.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the whole genome sequencing market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• BGI
• QIAGEN
• Agilent Technologies
• ProPhase Labs, Inc. (Nebula Genomics)
• Psomagen
• Azenta US, Inc. (GENEWIZ)
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In September 2024, MGI Tech Co., Ltd., a company committed to building core tools and technologies that drive innovation in life science, announced the global rights to commercialize and distribute the new sequencing products CycloneSEQ-WT02 and CycloneSEQ-WY01.
• In January 2024, Ultima Genomics launching high-end DNA sequencers that can read a genome for $100. The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the whole genome sequencing market based on the below-mentioned segments: 

Global Whole Genome Sequencing Market, By Product & Service

• Instruments
• Consumables
• Services

Global Whole Genome Sequencing Market, By Application

• Human Whole Genome Sequencing
• Plant Whole Genome Sequencing
• Animal Whole Genome Sequencing
• Microbial Whole Genome Sequencing

Global Whole Genome Sequencing Market, By End-use

• Academic & Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Global Whole Genome Sequencing Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa